Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Naturhouse HealthXMAD:NTH +1.98%81 EV-to-EBIT is 10.35 as of Jul. 24, 2026, which is 63% above its 10-year median of 6.34. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,559 Consumer Packaged Goods companies, Naturhouse Health ranks better than 58.63% on this metric.
Naturhouse Health (XMAD:NTH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Naturhouse Health's Enterprise Value for the quarter that ended in Dec. 2025 was €119.86 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naturhouse Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €13.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturhouse Health EV-to-EBIT Related Terms
Naturhouse Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Naturhouse Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Naturhouse Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturhouse Health EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Naturhouse Health's EV-to-EBIT falls into.
Naturhouse Health's current Enterprise Value is €142.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Naturhouse Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €13.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturhouse Health (XMAD:NTH) has a EV-to-EBIT of 10.35 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Naturhouse Health and its competitors. This is 63% above median its historical median of 6.34. Over the past decade, Naturhouse Health's EV-to-EBIT has ranged from 3.09 to 10.61. According to the industry distribution chart, Naturhouse Health ranks #645 out of 1559 companies in the Consumer Packaged Goods industry, placing it in the top 41.4%.
Is Naturhouse Health's EV-to-EBIT too high?
Naturhouse Health's current EV-to-EBIT of 10.35 is 63% above median its 10-year median of 6.34. Over the past 10 years, this metric has ranged from a low of 3.09 to a high of 10.61. The Consumer Packaged Goods industry median EV-to-EBIT is 11.99. Naturhouse Health's value of 10.35 is 13.7% below this industry median. Based on the distribution chart, Naturhouse Health ranks #645 out of 1559 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's EV-to-EBIT compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #645 out of 1559 companies for EV-to-EBIT. This puts Naturhouse Health in the upper half of its industry. The industry median EV-to-EBIT is 11.99. Naturhouse Health's value of 10.35 is 13.7% below this benchmark. Historically, Naturhouse Health's own EV-to-EBIT has ranged from 3.09 to 10.61 over the past decade. While the company's 10-year median is 6.34 vs. the industry median of 11.99, Naturhouse Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 11.99, based on 1,559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current EV-to-EBIT of 10.35 is 13.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 11.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current EV-to-EBIT is 10.35, which is 63% above median its own 10-year median of 6.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.58 — trading 59.3% above its estimated fair value. The current EV-to-EBIT is 10.35, which is 63% above median its 10-year median of 6.34 and 13.7% below the Consumer Packaged Goods industry median of 11.99. Naturhouse Health's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current EV-to-EBIT is 10.35 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?
Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued.
The current stock price of €2.58 is trading 59.3% above its estimated GF Value™ of €1.62.
GuruFocus considers Naturhouse Health to be Significantly Overvalued.
Key valuation signals for XMAD:NTH:
EV-to-EBIT: 10.35 (63% above median its 10-year median of 6.34)
GF Value™: €1.62 vs. price of €2.58 (59.3% above fair value)
Industry Position: 13.7% below the Consumer Packaged Goods median (#645 of 1559)
No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score
Get the complete analysis for XMAD:NTH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:NTH has been successfully added to your 
